Trikafta has transformed the treatment landscape for many people living with cystic fibrosis by targeting the underlying genetic cause of the condition. While the therapy offers significant benefits, long term management remains essential for maintaining lung health, nutrition, and overall well being. Regular monitoring, adherence to treatment plans, and healthy lifestyle.
Cystic fibrosis is a genetic condition that affects the lungs, digestive system, and other organs by causing thick, sticky mucus to build up in the body. Advances in treatment have improved quality of life and life expectancy for many individuals. One important development is Trikafta, a medication designed to address the underlying cause of cystic fibrosis in eligible patients. Understanding how Trikafta fits into long term care can help patients and families stay informed about treatment and disease management.